As in football, so in pharmaceuticals: The English have been beaten. Merck has outpaced AstraZeneca in the race to get the first US approval for an oral form of a particular kind of cholesterol-lowering medication. …
Source: Endpoints News
You may also like
Gene Therapy Partners Aim to Enhance Protein Expression
Modular Antibody–ADC Click Chemistry Overcomes Tumor...
See, Blind Mice: Consortium’s Drugs Restore Sight
Genetic Study Links Excessive Sweating to Neurological...
Parkinson’s in the Clinic, Insilico enters Phase...
KRAS-Targeted Vaccine Crosses First Clinical Milestone...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.